Price T Rowe Associates Inc Amphastar Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 583,906 shares of AMPH stock, worth $31.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
583,906
Previous 584,544
0.11%
Holding current value
$31.2 Million
Previous $25.7 Million
9.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AMPH
# of Institutions
282Shares Held
35.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$317 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$143 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$114 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$104 Million0.19% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$86.6 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.62B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...